Jesy Nelson’s heartbreaking truth behind historic SMA victory as she admits her baby twins are facing an uncertain future: ‘I’m trying to be hopeful, but it’s tough’

Jesy Nelson has achieved the change she fought so desperately for — a breakthrough that could transform the futures of countless babies and spare other families from experiencing the terrifying uncertainty she knows only too well.

But behind what should have been one of the proudest moments of her life lies a deeply personal heartache.

As England prepares to introduce newborn screening for spinal muscular atrophy (SMA), the former Little Mix star has revealed that the news feels painfully “bittersweet” because her own twin daughters, Ocean Jade and Story Monroe, are still facing an uncertain road.

The little girls were diagnosed with the severe genetic condition months after birth, by which point Jesy says irreversible damage may already have occurred.

Now, despite receiving potentially life-changing treatment, doctors are continuing to monitor how much muscle function and how many motor neurons may have been preserved.

And Jesy has admitted that recent assessments have brought worrying news.

“I’ll be honest with you, it’s not been great with the girls,” she revealed.

Their latest numbers, she explained, had gone down.

For a mother who has spent months fighting not only for her daughters but for babies she may never meet, it is a devastating contrast.

One battle has finally been won.

But the most personal battle of all is far from over.

A historic victory overshadowed by one heartbreaking thought

Jesy, 35, has become one of the most prominent voices calling for newborn SMA screening after Ocean and Story were diagnosed with SMA Type 1.

The condition affects the nerve cells responsible for sending signals from the brain and spinal cord to the muscles.

Without enough of a crucial protein produced by a healthy SMN1 gene, motor neurons can deteriorate, causing progressive muscle weakness.

Early diagnosis is particularly important because treatment can protect motor neurons that are still functioning, but damage that has already occurred may not be reversible.

That reality is at the heart of Jesy’s heartbreak.

After campaigning for babies to be tested much earlier, she finally received the news she had desperately hoped for: newborn SMA screening is set to be introduced in England, beginning with a phased rollout before expanding to all newborns.

It should have been a moment of pure celebration.

Instead, Jesy found herself thinking about one painful question.

What if this had happened earlier?

What if Ocean and Story had been tested at birth?

“It’s just amazing and it’s also a bit of a bittersweet feeling at the same time,” she admitted.

She made it clear that she was enormously grateful for the change, but could not ignore the sadness behind how her family became involved in the fight.

“If this had been taken seriously a few years ago, maybe my girls wouldn’t be in this situation.”

Those words reveal the emotional contradiction at the centre of her victory.

Jesy has helped push forward a change that could mean other parents receive answers before symptoms become obvious.

But she cannot turn back time for her own daughters.

‘It’s not been great with the girls’

Perhaps the most difficult revelation came when Jesy spoke about Ocean and Story’s current progress.

The twins continue to undergo assessments approximately every three months at Great Ormond Street Hospital, where specialists monitor their condition and response following treatment.

For Jesy, every assessment carries enormous emotional weight.

The results may offer clues about what progress the girls are making and whether additional treatment could be considered.

And according to Jesy, the latest numbers were not what she had hoped to hear.

“I’ll be honest with you, it’s not, it’s not been great with the girls,” she said.

“They have a three-month test… and their numbers went down.”

She explained that if doctors do not see the progress they hope for, the twins may need further treatment.

That possibility has left her frightened.

“If there’s no progress then they may have to go back on treatment, so it’s quite a scary time for me at the moment.”

It is a reminder that while headlines may celebrate a historic policy change, Jesy’s reality at home remains filled with appointments, assessments and questions that may not yet have clear answers.

For Ocean and Story, their story is still unfolding.

And their mother is living through every uncertain moment alongside them.

The diagnosis that changed everything

Jesy’s world changed when her daughters were diagnosed with SMA Type 1 at around six months old.

Before receiving the diagnosis, she had repeatedly sought medical advice as concerns about the twins grew.

Eventually, the devastating explanation arrived.

SMA is a rare inherited neuromuscular condition caused by a genetic problem affecting the production of survival motor neuron, or SMN, protein.

This protein plays a crucial role in maintaining motor neurons — the nerve cells that communicate with muscles and allow the body to move.

When those motor neurons are lost, muscles can become progressively weaker.

In severe forms of SMA, this can affect not only movement in the arms and legs but also important functions such as breathing, swallowing and feeding.

Around 50 babies are estimated to be born with SMA in the UK each year.

But what makes early screening so important is the speed at which damage can occur.

A baby can appear healthy at birth while changes are already happening inside the body.

By the time obvious symptoms emerge, valuable motor neurons may already have been lost.

That is why Jesy became so determined to push for newborn screening.

Her argument was painfully simple:

Why wait for a baby to show signs of illness if a test could identify the condition earlier?

The treatment that saved their lives — but couldn’t turn back time

Following their diagnosis, Ocean and Story received Zolgensma, a one-time gene therapy used to treat SMA.

The treatment works by delivering a functioning copy of the SMN1 gene, helping the body produce the crucial SMN protein that people with SMA lack.

For babies treated very early — particularly before significant symptoms develop — outcomes can be dramatically improved.

But timing matters.

And that is the painful reality Jesy cannot escape.

Her daughters received treatment after their diagnosis at six months rather than shortly after birth.

While the therapy can prevent further deterioration and preserve remaining function, it cannot necessarily restore motor neurons that have already been permanently lost.

Jesy does not underestimate what the treatment has done for her daughters.

Quite the opposite.

She described it as life-changing and potentially lifesaving.

But she also knows their situation might have looked very different if the condition had been detected immediately after birth.

“If they’d have got that from birth, then it would have been a whole different ball game,” she said.

For Jesy, those words carry enormous weight.

Because nobody can now say with certainty what might have been different.

‘We don’t know what is still working and what isn’t’

This uncertainty appears to be one of the hardest parts of the journey.

Doctors can treat.

They can monitor.

They can assess progress.

But they cannot simply rewind the months before diagnosis.

Jesy explained that the family is still trying to understand how much function was preserved before the twins received treatment.

“If you don’t get that treatment from birth you don’t know what muscles are dead and what can be saved,” she said.

“And unfortunately that is the problem with my girls at the moment.”

She described the uncertainty as feeling like “a guessing game”.

“We don’t know what is still working and what isn’t.”

For any parent, uncertainty about a child’s future is difficult.

For Jesy, it means watching every movement and waiting for every assessment while trying not to allow fear to overwhelm hope.

“I’m just trying to be hopeful, but it’s tough,” she admitted.

“It’s really tough.”

Few sentences better capture where she finds herself today.

Hopeful.

Terrified.

Grateful.

Heartbroken.

All at the same time.

What happens next for Ocean and Story?

The twins’ medical team will continue monitoring their progress closely.

Jesy has explained that another treatment, Evrysdi, may potentially be considered depending on how their condition develops and how specialists assess their needs.

Evrysdi, also known as risdiplam, is designed to help the body produce more functional SMN protein.

Unlike the one-time gene therapy the twins have already received, it is taken regularly.

For now, however, there is no simple prediction of exactly what Ocean and Story’s future will look like.

Jesy has previously spoken about being told that her daughters are unlikely to walk.

But every child with SMA can respond differently, particularly in an era when treatments are developing rapidly.

That leaves the family living somewhere between medical reality and hope.

Jesy is not pretending everything will suddenly become easy.

But she is also refusing to let a diagnosis become the only story her daughters inherit.

A change that could transform another baby’s entire future

The introduction of newborn screening represents exactly the kind of intervention Jesy wishes had been available to Ocean and Story.

Under the planned rollout, around two-thirds of newborn babies in England are expected to be included in SMA screening from October, with expansion to all newborns expected from October 2027.

The significance could be enormous.

Instead of waiting until a baby begins showing muscle weakness or missing developmental milestones, screening could identify SMA before obvious symptoms appear.

That could allow treatment to begin much earlier.

And with SMA, every week can matter.

For families who receive an early diagnosis in the future, the experience could therefore be very different from the one Jesy endured.

There may be no months of wondering why something seems wrong.

No repeated search for answers while the condition progresses silently.

No devastating discovery that valuable time may already have been lost.

That is the victory Jesy fought for.

Not because it can rewrite her daughters’ past.

But because it could rewrite somebody else’s future.

‘I wanted their story to be part of change’

Perhaps the most moving part of Jesy’s journey is the way she speaks about what Ocean and Story may one day understand about everything that happened.

When she first received their diagnosis, she was devastated.

But amid that heartbreak, another thought began to form.

If she could not change what had happened to her daughters, perhaps she could make their story mean something bigger.

“I just knew that I wanted to make the best out of it in any way I could,” she explained.

She wanted to push for change so that one day, when Ocean and Story are old enough to understand, she can tell them something extraordinary.

Their story helped other babies.

Their experience mattered.

Their struggle became part of something that could protect future generations.

“That’s going to be their little superpower,” Jesy said.

It is an extraordinarily powerful way for a mother to reframe something that brought her family so much pain.

She does not want her daughters to grow up believing SMA is the thing that defines them.

Instead, she wants them to understand how special they are.

“I want them to feel empowered,” she said.

“I want them to know how special they are and that this doesn’t define them.”

From pop star to mother fighting for answers

For years, the public knew Jesy Nelson through a completely different lens.

She was a member of one of Britain’s biggest girl groups.

There were hit songs, arena tours, red carpets, awards and millions of fans.

But motherhood has brought her into a world no amount of fame could have prepared her for.

Hospital corridors.

Genetic terminology.

Motor neuron assessments.

Treatment decisions.

Waiting for results.

And the overwhelming fear that comes with not knowing exactly what the future holds for your children.

Her new documentary, Jesy Nelson: Life Changing, follows this deeply personal chapter of her life and the transformation she has undergone since becoming a mother.

The timing of its release now carries even greater significance.

The cameras have captured a family living through an extraordinarily difficult medical journey.

But alongside that struggle came something nobody could guarantee when Jesy first began speaking out.

Change.

Real, measurable change.

A victory she wishes her daughters never had to inspire

There is a painful irony at the heart of this entire story.

Jesy got what she fought for.

Babies will be screened.

Families may receive answers sooner.

Treatment may begin before irreversible damage has occurred.

Future children with SMA may have opportunities that Ocean and Story did not have.

That is an extraordinary achievement.

But no mother would ever choose the circumstances that made the fight necessary.

That is why Jesy’s happiness is mixed with grief.

She can celebrate the babies who may now be helped while still grieving what might have been possible for her own daughters.

Both emotions can exist together.

And perhaps that is what makes her reaction so deeply human.

Ocean and Story’s ‘little superpower’

One day, Ocean and Story will be old enough to hear the full story.

They may learn about the terrifying months when their mother searched for answers.

They may learn about the diagnosis that changed their family forever.

They may learn about the treatments, hospital visits and uncertainty.

But Jesy wants them to learn something else too.

She wants them to know that their lives helped create change.

Because of the attention brought to their experience and the wider campaign for earlier detection, other families may one day receive an SMA diagnosis before their baby shows serious symptoms.

Other parents may be able to begin treatment sooner.

Other children may face a different future.

For Jesy, that knowledge is something she hopes her daughters can carry with pride rather than sadness.

At the very moment she should be celebrating one of the biggest victories of her life, she remains focused on two little girls whose futures she still cannot predict.

The latest assessments have brought new anxiety.

More decisions may lie ahead.

There are still questions doctors cannot fully answer.

But Jesy is holding tightly to hope.

And behind every hospital appointment, every frightening result and every uncertain tomorrow is one promise she seems determined to keep:

Ocean and Story will never be defined only by SMA.

Their mother will make sure they grow up knowing that their story became part of something bigger.

A change that came too late to give Jesy the early diagnosis she desperately wishes her daughters had received — but one that could give countless babies after them the precious gift of time.

For Jesy Nelson, that is why this historic victory will always carry two emotions at once.

Immense pride for the future she helped change.

And a mother’s quiet heartbreak for the past she can never rewrite.